DALLAS & NEW YORK & LONDON & TOKYO–(BUSINESS WIRE)–Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position … [Read more…]
PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–#ClinicalExcellence–Viper Partners, a healthcare-focused advisory firm, is pleased to announce that it served as the exclusive advisor to Vascular Specialists in its strategic partnership with CUC America, a leading healthcare services organization focused on supporting physician-led specialty platforms. Vascular Specialists is a premier vascular care provider dedicated to delivering comprehensive diagnosis … [Read more…]
OTTAWA, Ontario–(BUSINESS WIRE)–On International Women’s Day (March 8), Canadian policymakers are being warned that strict controls on oral nicotine pouches are limiting access to an innovation linked to one of the world’s sharpest declines in female smoking. The warning accompanies the release of a new report, Empowerment in a Pouch, documenting how access to tobacco-free … [Read more…]
LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 100.000 percent of the principal amount (the “Junior Subordinated Notes Offering”). The Junior Subordinated Notes Offering is expected to close on March … [Read more…]
* Although Oasis generally supports the separation of business execution and oversight, Oasis is calling on shareholders to vote AGAINST Kobayashi Pharma transitioning to a Company with an Audit and Supervisory Committee, as Oasis believes it may further entrench the founding family’s control over the Company * Oasis continues to urge all shareholders to vote … [Read more…]
– Reported positive top-line data from Phase 2a proof-of-concept (POC) trial of EVO301 in atopic dermatitis (AD) – EVO756 on track to report Phase 2b top-line data in chronic spontaneous urticaria (CSU) and AD in 2Q26 and 2H26, respectively – Strengthened balance sheet with $125 million private placement to support additional clinical milestones and extend … [Read more…]
Prince’s expertise will advance CHG’s integrated staffing model, pairing immediate locums solutions with long‑term permanent placement strategies MIDVALE, Utah–(BUSINESS WIRE)–CHG Healthcare announces that Ema Prince has been named President of CompHealth’s Permanent Placement Division, reinforcing the company’s enterprise-wide strategy to help healthcare organizations build stable, long‑term clinical workforces in the face of continued physician shortages. … [Read more…]
EL SEGUNDO, Calif.–(BUSINESS WIRE)–Greater Good Health, a premier partner to risk-bearing organizations in managing total cost of care, announced today a $20.5 million Series B financing led by Allumia Ventures, along with up to $12.5 million in a venture debt facility from HSBC Innovation Banking. Participation came from new investors DaVita Venture Group and Granite … [Read more…]
HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced plans to present at the upcoming virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference. Pulse Biosciences’ Management is scheduled to present on Wednesday, March 18, 2026, at … [Read more…]
HANGZHOU, China–(BUSINESS WIRE)–Recently, the winners of the prestigious French Design Awards, often referred to as the “pinnacle” of the design world, have been announced. In this award selection, GUTX, a professional probiotic brand produced by Siliankang® under Hangzhou Grand Biologic Pharmaceutical INC won the 2025 French Design Awards for its world-first “Dual-Compartment Fresh Probiotic” packaging … [Read more…]
